These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 25568140)

  • 1. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower value of glycated haemoglobin relative to glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
    Shima K; Chujo K; Yamada M; Komatsu M; Noma Y; Mizuguchi T
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):68-74. PubMed ID: 22194360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes.
    Kumeda Y; Inaba M; Shoji S; Ishimura E; Inariba H; Yabe S; Okamura M; Nishizawa Y
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):556-61. PubMed ID: 18248645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
    Hasslacher C; Kulozik F
    J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
    Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
    Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M
    Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insights on glycated albumin].
    Hay-Lombardie A; Kamel S; Bigot-Corbel E
    Ann Biol Clin (Paris); 2019 Aug; 77(4):407-414. PubMed ID: 31418702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
    Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
    J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.
    Wada N; Mori K; Nakagawa C; Sawa J; Kumeda Y; Shoji T; Emoto M; Inaba M
    J Diabetes Complications; 2015; 29(8):1310-3. PubMed ID: 26298521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated albumin in diabetic patients with chronic kidney disease.
    Zheng CM; Ma WY; Wu CC; Lu KC
    Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients.
    Suzuki K; Yagi K; Oka R; Saiki Y; Kubota M; Sugihara M; Ito N; Kawashiri MA; Nohara A; Horita H; Takeda Y; Yamagishi M; Kobayashi J
    Clin Chem Lab Med; 2009; 47(1):70-4. PubMed ID: 19072031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.
    Wang N; Xu Z; Han P; Li T
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct biomarker roles for HbA
    Hayashi A; Takano K; Masaki T; Yoshino S; Ogawa A; Shichiri M
    J Diabetes Complications; 2016; 30(8):1494-1499. PubMed ID: 27614726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of albumin leakage on glycated albumin in patients with type 2 diabetes undergoing hemodialysis.
    Ueda S; Nagai K; Yokota N; Hirose D; Mori H; Noma Y; Doi T; Minakuchi J
    J Artif Organs; 2019 Sep; 22(3):264-267. PubMed ID: 30805746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study.
    George C; Matsha TE; Korf M; Zemlin AE; Erasmus RT; Kengne AP
    BMC Nephrol; 2020 Jan; 21(1):32. PubMed ID: 32000712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.
    Jung M; Warren B; Grams M; Kwong YD; Shafi T; Coresh J; Rebholz CM; Selvin E
    J Diabetes; 2018 Apr; 10(4):276-285. PubMed ID: 29055090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.